- DL Recommends: Moderate Sell
- This is recommended as Moderate sell as this stock is expected to do slightly worse than the overall stock market return.
Key Fundamentals of CIPLA
- Sector:
- PHARMA
- Category:
- Large Cap
| Profit after Tax | 1527.70 | Book Value | 190.32 |
| PE Ratio | 25.54 | Institutions Holding | 747 |
| Market Capitalization | 39021.42 | ||
| Debt to Equity Ratio | 0.29 | EBIDTA | 1771.00 |
| Dividend Yield | 0.61 | Promoter's Pledge (%) | 0.00 |
Correction Levels to Buy(From recent high)
| Recent High | 1277.90 |
| 10% Correction | 1150.11 |
| 20% Correction | 1022.32 |
| 30 % Correction | 894.53 |
Strong Support Technical Buy Levels(Monthly & Weekly Levels)
| Week 4 Level | 452.00 |
Chart
We recomend to use Weekly and Monthly charts. Daily charts are also given which are used for exits. We donot recomend daily/intraday minuite, hourly charts. The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit exit.
| Exchange Symbol | CIPLA (NSE) |
|---|---|
| Sector | Healthcare |
| Current Price * (Rs.) | 1164.05 |
| Face Value (Rs.) | 2 |
| 52 Week High (Rs.) | 586.00 (27-May-19) |
| 52 Week Low (Rs.) | 389.55 (11-Oct-19) |
| Life Time high (Rs.) | 752.85 (10-Mar-15) |
| Life Time low (Rs.) | 5.97 (22-Nov-95) |
| Average Daily Movement [ADM] | 25.31 |
| Average Volume [20 days] | 1678012 |
| Average Value [1 Year] | 191.70 (Cr) |
| 1 Month Return (%) | 5.61 |
| Consolidated FY 15-16 PE Ratio | 25.54 |
| Consolidated Trailing PE Ratio | 23.65 |
| Standalone FY 15-16 PE Ratio | 20.66 |
| Standalone Trailing PE Ratio | 16.52 |
| Book Value | 190.32 |
| Market Cap | 39021.42 (Cr) |
| % of Promoter holding pledged | 0 |
Get to know the CIPLA share price & overview of CIPLA, 52 week highs/lows & lifetime highs/lows, average volume, adm & 1 month return %.
